For rheumatoid arthritis, they are not replacements for your DMARD or biologic but the 2025 research from centers like UCLA suggests they can be a powerful complement: less disease activity, fewer flares, lower inflammation markers, better cholesterol and blood sugar, and reduced cardiovascular risk sometimes even at low doses
If youre considering a GLP-1 medication, focus on the proven benefits for diabetes management and weight loss
Effectiveness for binge eating disorder (BED) Clinical trials found Vyvanse to be effective for reducing binge eating episodes in adults with moderate to severe binge eating disorder (BED)
FUTURE PERSPECTIVES The emergence of SGLT2 inhibitors and GLP1 receptor agonists represents a major advancement in the management of DKD
Sacubitril/valsartan (LCZ696) Significantly Reduces Aldosterone and Increases cGMP Circulating Levels in a Canine Model of RAAS Activation
However, the specific pathways or pathways involved are not clear enough and need further research and exploration